Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Kranz, M. Diken, H. Haas, S. Kreiter, C. Loquai, K. Reuter, M. Meng, D. Fritz, F. Vascotto, Hossam Hefesha, C. Grunwitz, M. Vormehr, Yves Hüsemann, Abderraouf Selmi, A. Kuhn, Janina Buck, E. Derhovanessian, Richard Rae, S. Attig, Jan Diekmann, R. Jabulowsky, S. Heesch, J. Hassel, P. Langguth, S. Grabbe, C. Huber, Ö. Türeci, U. Şahin (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyNature, 534
S. Gross, M. Erdmann, I. Haendle, S. Voland, T. Berger, E. Schultz, E. Strasser, P. Dankerl, R. Janka, S. Schliep, L. Heinzerling, K. Sotlar, P. Coulie, G. Schuler, B. Schuler-Thurner (2017)
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.JCI insight, 2 8
P. Kantoff, C. Higano, N. Shore, E. Berger, E. Small, D. Penson, C. Redfern, A. Ferrari, R. Dreicer, R. Sims, Yi Xu, M. Frohlich, P. Schellhammer (2010)
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.The New England journal of medicine, 363 5
O. Ali, Nathaniel Huebsch, Lan Cao, G. Dranoff, D. Mooney (2008)
Infection-Mimicking Materials to Program Dendritic Cells In SituNature materials, 8
S. Chaudhry, J. Mattera, J. Curtis, J. Spertus, J. Herrin, Zhenqiu Lin, C. Phillips, Beth Hodshon, L. Cooper, H. Krumholz (2010)
Telemonitoring in patients with heart failure.The New England journal of medicine, 363 24
Jinjun Shi, P. Kantoff, R. Wooster, O. Farokhzad (2016)
Cancer nanomedicine: progress, challenges and opportunitiesNature Reviews Cancer, 17
L. Bonifaz, D. Bonnyay, K. Mahnke, M. Rivera, M. Nussenzweig, R. Steinman (2002)
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell ToleranceThe Journal of Experimental Medicine, 196
P. Tacken, I. Zeelenberg, L. Cruz, Maaike Hout-Kuijer, G. Glind, R. Fokkink, A. Lambeck, C. Figdor (2011)
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity.Blood, 118 26
G. Schreibelt, K. Bol, H. Westdorp, F. Wimmers, E. Aarntzen, T. Boer, M. Rakt, N. Scharenborg, A. Boer, J. Pots, M. Nordkamp, T. Oorschot, J. Tel, Gregor Winkels, Katja Petry, W. Blokx, M. Rossum, M. Welzen, R. Mus, S. Croockewit, R. Koornstra, J. Jacobs, S. Kelderman, C. Blank, W. Gerritsen, C. Punt, C. Figdor, I. Vries (2015)
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic CellsClinical Cancer Research, 22
K. Bol, G. Schreibelt, W. Gerritsen, I. Vries, C. Figdor (2016)
Dendritic Cell–Based Immunotherapy: State of the Art and BeyondClinical Cancer Research, 22
D. Dudziak, A. Kamphorst, Gordon Heidkamp, V. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, Kang Liu, Han-Woong Lee, Chae Park, R. Steinman, M. Nussenzweig (2007)
Differential Antigen Processing by Dendritic Cell Subsets in VivoScience, 315
Camille M. Le Gall, Jorieke Weiden, Loek J. Eggermont and Carl G. Figdor provide an overview of immunotherapeutics for cancer treatment that harness dendritic cells, their challenges in clinical use, and approaches employed to enhance their recruitment and activation to promote effective anti-tumour immunity.
Nature Materials – Springer Journals
Published: May 23, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.